BIRC5 and myeloid leukemia: We have previously reported that VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating survivin.27 In this study, we found that HDAC1 and HDAC2 had an important role in myeloid leukemia cells.